SLC2A1 and diabetes mellitus: In addition to hypothesis-driven studies (i.e., the gene-candidate association studies), hypothesis-free studies such as GWAS [23,52,53], microarrays gene expression analyses [54,55] and whole genome linkage scans [56,57] may assist in providing more conclusive evidence regarding the significance of SLC2A1 as a marker in diabetes leading to complication.